Maja Sirotković-Skerlev

424 total citations
20 papers, 319 citations indexed

About

Maja Sirotković-Skerlev is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Maja Sirotković-Skerlev has authored 20 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 7 papers in Cancer Research and 6 papers in Molecular Biology. Recurrent topics in Maja Sirotković-Skerlev's work include Cell Adhesion Molecules Research (5 papers), Cancer Cells and Metastasis (3 papers) and Peptidase Inhibition and Analysis (3 papers). Maja Sirotković-Skerlev is often cited by papers focused on Cell Adhesion Molecules Research (5 papers), Cancer Cells and Metastasis (3 papers) and Peptidase Inhibition and Analysis (3 papers). Maja Sirotković-Skerlev collaborates with scholars based in Croatia and Belgium. Maja Sirotković-Skerlev's co-authors include Vincent Timmerman, Eva Nelis, Kristl G. Claeys, Nina Barišić, A. Löfgren, Peter De Jonghe, Damir Vrbanec, Sanja Kapitanović, Krešimir Pavelić and Šimun Križanac and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Annals of Human Genetics.

In The Last Decade

Maja Sirotković-Skerlev

19 papers receiving 313 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maja Sirotković-Skerlev Croatia 10 145 95 81 53 47 20 319
Simone Kutschera United States 4 209 1.4× 75 0.8× 51 0.6× 49 0.9× 38 0.8× 4 289
Arend H. Sikkema Netherlands 9 196 1.4× 46 0.5× 50 0.6× 32 0.6× 72 1.5× 12 340
Michael S. Lam United States 9 152 1.0× 63 0.7× 44 0.5× 103 1.9× 75 1.6× 13 365
Patricia Fernández‐Nogueira Spain 9 183 1.3× 108 1.1× 112 1.4× 50 0.9× 42 0.9× 13 357
Hailian Shen China 11 228 1.6× 48 0.5× 55 0.7× 36 0.7× 44 0.9× 19 414
Verónica Rivas Spain 11 367 2.5× 73 0.8× 101 1.2× 51 1.0× 53 1.1× 19 473
Pardis Azmoon United States 11 164 1.1× 74 0.8× 38 0.5× 86 1.6× 107 2.3× 18 389
Scott Ditch United States 5 378 2.6× 102 1.1× 80 1.0× 76 1.4× 30 0.6× 8 475
Russell Williams United States 8 273 1.9× 56 0.6× 50 0.6× 107 2.0× 29 0.6× 8 418
Manisha Juneja Germany 11 286 2.0× 147 1.5× 82 1.0× 67 1.3× 19 0.4× 14 463

Countries citing papers authored by Maja Sirotković-Skerlev

Since Specialization
Citations

This map shows the geographic impact of Maja Sirotković-Skerlev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maja Sirotković-Skerlev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maja Sirotković-Skerlev more than expected).

Fields of papers citing papers by Maja Sirotković-Skerlev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maja Sirotković-Skerlev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maja Sirotković-Skerlev. The network helps show where Maja Sirotković-Skerlev may publish in the future.

Co-authorship network of co-authors of Maja Sirotković-Skerlev

This figure shows the co-authorship network connecting the top 25 collaborators of Maja Sirotković-Skerlev. A scholar is included among the top collaborators of Maja Sirotković-Skerlev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maja Sirotković-Skerlev. Maja Sirotković-Skerlev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bojanac, Ana Katušić, et al.. (2023). 301P Epigenetic modifications of IL-17 gene in patients with early breast cancer and healthy controls. Annals of Oncology. 34. S304–S304.
3.
Sirotković-Skerlev, Maja, et al.. (2020). Prognostic value of circulating Bcl-2 and anti-p53 antibodies in patients with breast cancer: A long term follow-up (17.5 years). Cancer Biomarkers. 30(1). 95–104. 8 indexed citations
4.
Šepac, Ana, Davor Miličić, Joško Bulum, et al.. (2020). Mitochondrial unfolded protein response, mitophagy and other mitochondrial quality control mechanisms in heart disease and aged heart. Croatian Medical Journal. 61(2). 126–138. 30 indexed citations
5.
Gamulin, Stjepan, et al.. (2016). Telomerase activity in breast cancer patients: association with poor prognosis and more aggressive phenotype. Medical Oncology. 33(3). 23–23. 17 indexed citations
6.
7.
Sirotković-Skerlev, Maja, et al.. (2014). Sirtuins in tumorigenesis. Periodicum Biologorum. 116(4). 381–386. 3 indexed citations
8.
Jakić‐Razumović, Jasminka, et al.. (2014). Prognostic Value of Ki-67 in Breast Carcinoma: Tissue Microarray Method Versus Whole Section Analysis- Potentials and Pitfalls. Pathology & Oncology Research. 21(2). 315–324. 2 indexed citations
9.
Sirotković-Skerlev, Maja, et al.. (2012). Protumor effects of proinflammatory mediators in breast cancer. Hrčak Portal of scientific journals of Croatia (University Computing Centre). 4 indexed citations
10.
Sirotković-Skerlev, Maja, et al.. (2012). Low serum MMP-1 in breast cancer: a negative prognostic factor?. Biomarkers. 17(5). 416–421. 11 indexed citations
11.
12.
13.
Sirotković-Skerlev, Maja, et al.. (2009). Anti-p53 antibodies in serum: relationship to tumor biology and prognosis of breast cancer patients. Medical Oncology. 27(3). 887–893. 21 indexed citations
14.
Skerlev, M., et al.. (2009). Molluscum contagiosum. Der Hautarzt. 60(6). 472–476. 3 indexed citations
15.
Barišić, Nina, Kristl G. Claeys, Maja Sirotković-Skerlev, et al.. (2008). Charcot‐Marie‐Tooth Disease: A Clinico‐genetic Confrontation. Annals of Human Genetics. 72(3). 416–441. 119 indexed citations
16.
Sirotković-Skerlev, Maja, Tamara Čaćev, & Sanja Kapitanović. (2007). Tumor necrosis factor alpha and breast cancer. Periodicum Biologorum. 108(5). 541–546. 1 indexed citations
17.
Sirotković-Skerlev, Maja, et al.. (2007). TNF alpha promoter polymorphisms analysis in benign and malignant breast lesions. Experimental and Molecular Pathology. 83(1). 54–58. 24 indexed citations
18.
Sirotković-Skerlev, Maja, et al.. (2006). [Pathophysiology of ischaemia-reperfusion injury].. PubMed. 128(3-4). 87–95. 9 indexed citations
19.
Vrbanec, Damir, et al.. (2006). [Gastrointestinal stromal tumors (GIST)--a paradigm of successful targeted therapy of solid tumors].. PubMed. 60(5). 471–5. 2 indexed citations
20.
Sirotković-Skerlev, Maja, et al.. (2005). Expression of c-myc, erbB-2, p53 and nm23-H1 gene product in benign and malignant breast lesions: coexpression and correlation with clinicopathologic parameters. Experimental and Molecular Pathology. 79(1). 42–50. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simone Kutschera Breakdown of academic impact, for papers by Arend H. Sikkema Breakdown of academic impact, for papers by Michael S. Lam Breakdown of academic impact, for papers by Patricia Fernández‐Nogueira Breakdown of academic impact, for papers by Hailian Shen Breakdown of academic impact, for papers by Verónica Rivas Breakdown of academic impact, for papers by Pardis Azmoon Breakdown of academic impact, for papers by Scott Ditch Breakdown of academic impact, for papers by Russell Williams Breakdown of academic impact, for papers by Manisha Juneja
Rankless by CCL
2026